Risk stratification of allogeneic stem cell recipients with respect to the potential for development of GVHD via their pre-transplant plasma lipid and metabolic signature
D. Contaifer, C. H. Roberts, N. G. Kumar, R. Natarajan, B. J. Fisher, K. Leslie, J. Reed, A. A. Toor, D. S. Wijesinghe
This study identifies pre-transplant plasma lipid and metabolic biomarkers that predict graft vs. host disease (GVHD) risk in allogeneic stem cell transplant recipients with high accuracy.
bioRxiv · Nov 20, 2018Biochemistry